This is the blog for CARG, the Coronary Artery Rehabilitation Group, based in Saskatoon, Saskatchewan, Canada. It will contain items of interest to CARG's own members and anybody else interested in the latest news about rehabilitation and heart-related matters. Canadian charitable number: 89675 0163 RR 0001 || e-mail: carg.ca@gmail.com || website: carg.ca || Blog disclaimer
Thursday, April 2, 2009
Caraco Pharma recalls heart drug Digoxin
"Caraco Pharmaceutical Laboratories Ltd said it was recalling batches of the heart drug Digoxin distributed prior to March 31, saying these tablets could vary in size and thus dosage levels. While a lower than labeled dosage may pose a risk of lack of efficacy resulting in cardiac instability, excessive intake of the drug could lead to death, the company said. Shares of the company closed down about 23 percent at $3.52 Tuesday on the American Stock Exchange. Digoxin is a generic version of GlaxoSmithKline Plc's drug Lanoxin to treat heart failure and abnormal heart rhythms. The company said it was voluntarily recalling 0.125 mg and 0.25 mg tablets of the drug to the consumer level. Digoxin toxicity can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability, and bradycardia, the company said" - Reuters
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment